Black Barn Capital Partners LP Viking Therapeutics, Inc. Transaction History
Black Barn Capital Partners LP
- $1.72 Billion
- Q2 2025
A detailed history of Black Barn Capital Partners LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Black Barn Capital Partners LP holds 350,000 shares of VKTX stock, worth $9.98 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
350,000Holding current value
$9.98 Million% of portfolio
0.54%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
454Shares Held
68.3MCall Options Held
7.72MPut Options Held
3.31M-
Vanguard Group Inc Valley Forge, PA10.2MShares$290 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$172 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$108 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$92.6 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$89.2 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.19B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...